Expressions of cyclooxygenase-2 and epidermal growth factor receptor in non-small cell lung cancer

Xilin Dong,Yong Zhang,Ming Xie

DOI: https://doi.org/10.3969/j.issn.1672-9463.2006.11.002

2007-01-01

Abstract:Objective To study the expressions of cyclooxy genase-2(COX-2)and epidermal growth factor receptor(EGFR)in tumor tissue and explored the effect of COX-2 and EGFR in NSCLC development.Methods The expression of COX-2 and EGFR were detected by immunohistochemical techniquls in 56 cases of NSCLC and in 20 cases of normal lung tissues.Results The expression of COX-2 and EGFR in NSCLC were significantly higher than that in normal lung tissues(P<0.01),the positive expression rate of COX-2 and EGFR were 64.2% and 67.8%(respectively).The expressions of COX-2 and EGFR in NSCLC were associated with clinical stage,histologic grade,tumor pathological type and lymponode metastasis(P<0.05).The expression of COX-2 and EGFR in the stage III and stage IV of NSCLC were significantly higher than those in stage I and stage II of NSCLC.The expressions of COX-2 and EGFR in the worse differentiated NSCLC were significantly higher than those in the well differentiated NSCLC,and Lymponode metastasis in NSCLC were higher than non-lymponod metastasis(P<0.05).The expression of COX-2 in adenocarcinoma cell was obviously higher than that in squmaous cell carcinoma,the expression of EGFR in squmaous cell carcinoma was higher than that in adenocarcinoma cell(P<0.05).The positive correlation was found between COX-2 and EGFR.Conclusion The experiment suggests that COX-2 and EGFR play roles in nocogenesis and progression of NSCLC.So the expression of COX-2 and EGFR seems to be a useful tumor marker for patients with NSCLC and can be used to evaluate the tumor biological behavior and prognosis.